Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient

A 35‐year‐old male patient was diagnosed with stage IIC skin melanoma that rapidly progressed after surgery. Treatment was continued with radiotherapy, which did not stop further spread of disease and the patient was put on a combination of nivolumab and Rigvir. Subsequently, the progression has slo...

Descripción completa

Detalles Bibliográficos
Autores principales: Brokāne, Linda, Jaunalksne, Inta, Tilgase, Andra, Olmane, Evija, Petroška, Donatas, Rasa, Agnija, Alberts, Pēteris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552946/
https://www.ncbi.nlm.nih.gov/pubmed/31183092
http://dx.doi.org/10.1002/ccr3.2182
_version_ 1783424706031910912
author Brokāne, Linda
Jaunalksne, Inta
Tilgase, Andra
Olmane, Evija
Petroška, Donatas
Rasa, Agnija
Alberts, Pēteris
author_facet Brokāne, Linda
Jaunalksne, Inta
Tilgase, Andra
Olmane, Evija
Petroška, Donatas
Rasa, Agnija
Alberts, Pēteris
author_sort Brokāne, Linda
collection PubMed
description A 35‐year‐old male patient was diagnosed with stage IIC skin melanoma that rapidly progressed after surgery. Treatment was continued with radiotherapy, which did not stop further spread of disease and the patient was put on a combination of nivolumab and Rigvir. Subsequently, the progression has slowed.
format Online
Article
Text
id pubmed-6552946
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65529462019-06-10 Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient Brokāne, Linda Jaunalksne, Inta Tilgase, Andra Olmane, Evija Petroška, Donatas Rasa, Agnija Alberts, Pēteris Clin Case Rep Case Reports A 35‐year‐old male patient was diagnosed with stage IIC skin melanoma that rapidly progressed after surgery. Treatment was continued with radiotherapy, which did not stop further spread of disease and the patient was put on a combination of nivolumab and Rigvir. Subsequently, the progression has slowed. John Wiley and Sons Inc. 2019-05-08 /pmc/articles/PMC6552946/ /pubmed/31183092 http://dx.doi.org/10.1002/ccr3.2182 Text en © 2019 Rigvir. Clinical Case Reports Published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Brokāne, Linda
Jaunalksne, Inta
Tilgase, Andra
Olmane, Evija
Petroška, Donatas
Rasa, Agnija
Alberts, Pēteris
Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient
title Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient
title_full Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient
title_fullStr Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient
title_full_unstemmed Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient
title_short Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient
title_sort combination treatment with nivolumab and rigvir of a progressive stage iic skin melanoma patient
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552946/
https://www.ncbi.nlm.nih.gov/pubmed/31183092
http://dx.doi.org/10.1002/ccr3.2182
work_keys_str_mv AT brokanelinda combinationtreatmentwithnivolumabandrigvirofaprogressivestageiicskinmelanomapatient
AT jaunalksneinta combinationtreatmentwithnivolumabandrigvirofaprogressivestageiicskinmelanomapatient
AT tilgaseandra combinationtreatmentwithnivolumabandrigvirofaprogressivestageiicskinmelanomapatient
AT olmaneevija combinationtreatmentwithnivolumabandrigvirofaprogressivestageiicskinmelanomapatient
AT petroskadonatas combinationtreatmentwithnivolumabandrigvirofaprogressivestageiicskinmelanomapatient
AT rasaagnija combinationtreatmentwithnivolumabandrigvirofaprogressivestageiicskinmelanomapatient
AT albertspeteris combinationtreatmentwithnivolumabandrigvirofaprogressivestageiicskinmelanomapatient

Ejemplares similares